Year |
Citation |
Score |
2022 |
Parisotto M, Vuong-Robillard N, Kalegari P, Meharwade T, Joumier L, Igelmann S, Bourdeau V, Rowell MC, Pollak M, Malleshaiah M, Schmitzer A, Ferbeyre G. The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Cancers. 14. PMID 36428689 DOI: 10.3390/cancers14225597 |
0.357 |
|
2021 |
Del Toro N, Lessard F, Bouchard J, Mobasheri N, Guillon J, Igelmann S, Tardif S, Buffard T, Bourdeau V, Brakier-Gingras L, Ferbeyre G. Cellular Senescence limits Translational Readthrough. Biology Open. PMID 34676390 DOI: 10.1242/bio.058688 |
0.643 |
|
2021 |
Igelmann S, Lessard F, Uchenunu O, Bouchard J, Fernandez-Ruiz A, Rowell MC, Lopes-Paciencia S, Papadopoli D, Fouillen A, Ponce KJ, Huot G, Mignacca L, Benfdil M, Kalegari P, Wahba HM, ... ... Bourdeau V, et al. A hydride transfer complex reprograms NAD metabolism and bypasses senescence. Molecular Cell. 81: 3848-3865.e19. PMID 34547241 DOI: 10.1016/j.molcel.2021.08.028 |
0.318 |
|
2019 |
Saint-Germain E, Mignacca L, Huot G, Acevedo M, Moineau-Vallée K, Calabrese V, Bourdeau V, Rowell MC, Ilangumaran S, Lessard F, Ferbeyre G. Phosphorylation of SOCS1 inhibits the SOCS1-p53 tumor suppressor axis. Cancer Research. PMID 31101761 DOI: 10.1158/0008-5472.Can-18-1503 |
0.437 |
|
2019 |
Del Toro N, Fernandez-Ruiz A, Mignacca L, Kalegari P, Rowell MC, Igelmann S, Saint-Germain E, Benfdil M, Lopes-Paciencia S, Brakier-Gingras L, Bourdeau V, Ferbeyre G, Lessard F. Ribosomal protein Rpl22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex. Cell Cycle (Georgetown, Tex.). PMID 30874462 DOI: 10.1080/15384101.2019.1593708 |
0.674 |
|
2019 |
Deschênes-Simard X, Parisotto M, Rowell MC, Le Calvé B, Igelmann S, Moineau-Vallée K, Saint-Germain E, Kalegari P, Bourdeau V, Kottakis F, Bardeesy N, Ferbeyre G. Circumventing senescence is associated with stem cell properties and metformin sensitivity. Aging Cell. e12889. PMID 30614183 DOI: 10.1111/Acel.12889 |
0.455 |
|
2018 |
Lessard F, Igelmann S, Trahan C, Huot G, Saint-Germain E, Mignacca L, Del Toro N, Lopes-Paciencia S, Le Calvé B, Montero M, Deschênes-Simard X, Bury M, Moiseeva O, Rowell MC, Zorca CE, ... ... Bourdeau V, et al. Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biology. PMID 29941930 DOI: 10.1038/S41556-018-0127-Y |
0.673 |
|
2018 |
McManus FP, Bourdeau V, Acevedo M, Lopes-Paciencia S, Mignacca L, Lamoliatte F, Rojas Pino JW, Ferbeyre G, Thibault P. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9. Scientific Reports. 8: 7754. PMID 29773808 DOI: 10.1038/S41598-018-25150-Z |
0.418 |
|
2018 |
Ferbeyre G, Parisotto M, Rowell M, Bourdeau V, Schmitzer AR. Abstract 1864: Pharmacologic inhibition of NAMPT sensitizes pancreatic cancer cells to the antineoplastic effects of metformin Cancer Research. 78: 1864-1864. DOI: 10.1158/1538-7445.Am2018-1864 |
0.409 |
|
2016 |
Bourdeau V, Ferbeyre G. CDK4-CDK6 inhibitors induce autophagy-mediated degradation of DNMT1 and facilitate the senescence antitumor response. Autophagy. 0. PMID 27532423 DOI: 10.1080/15548627.2016.1214779 |
0.521 |
|
2016 |
Acevedo M, Vernier M, Mignacca L, Lessard F, Huot G, Moiseeva O, Bourdeau V, Ferbeyre G. A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence. Cancer Research. 76: 3252-64. PMID 27206849 DOI: 10.1158/0008-5472.Can-15-2347 |
0.517 |
|
2016 |
Mukhopadhyay UK, Cass J, Raptis L, Craig AW, Bourdeau V, Varma S, Gupta SS, Elliott BE, Ferbeyre G. Dataset of STAT5A status in breast cancer. Data in Brief. 7: 490-2. PMID 27014737 DOI: 10.1016/J.Dib.2016.02.073 |
0.304 |
|
2016 |
Mukhopadhyay UK, Cass J, Raptis L, Craig AW, Bourdeau V, Varma S, SenGupta S, Elliott BE, Ferbeyre G. STAT5A is regulated by DNA damage via the tumor suppressor p53. Cytokine. PMID 26876578 DOI: 10.1016/J.Cyto.2016.01.013 |
0.383 |
|
2016 |
Mignacca L, Saint-Germain E, Benoit A, Bourdeau V, Moro A, Ferbeyre G. Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers. Cytokine. PMID 26841929 DOI: 10.1016/J.Cyto.2016.01.015 |
0.328 |
|
2015 |
Cappadocia L, Mascle XH, Bourdeau V, Tremblay-Belzile S, Chaker-Margot M, Lussier-Price M, Wada J, Sakaguchi K, Aubry M, Ferbeyre G, Omichinski JG. Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1. Structure (London, England : 1993). 23: 126-38. PMID 25497731 DOI: 10.1016/J.Str.2014.10.015 |
0.331 |
|
2015 |
Calvé Bl, Deschenes-Ximard X, Kottakis F, Bourdeau V, Lessard F, Moineau-Vallée K, Saint-Germain E, Fitamant J, Perera RM, Bardeesy N, Ferbeyre G. Abstract 2154: ERK/MAPK pathway inhibits tumorigenesis and cellular reprogramming of pancreatic cancer cells Cancer Research. 75: 2154-2154. DOI: 10.1158/1538-7445.Am2015-2154 |
0.444 |
|
2015 |
Lessard F, Bourdeau V, Igelmann S, Deschênes-Simard X, Montero M, Ferbeyre G. Abstract 1270: Ribosome biogenesis is reduced by oncogenic stress in normal cells and is sufficient to trigger cellular senescence Cancer Research. 75: 1270-1270. DOI: 10.1158/1538-7445.Am2015-1270 |
0.369 |
|
2014 |
Bourdeau V, Ferbeyre G. Engaging a senescent response to cure leukemia. Nature Medicine. 20: 123-4. PMID 24504403 DOI: 10.1038/Nm.3469 |
0.405 |
|
2014 |
Huot G, Vernier M, Bourdeau V, Doucet L, Saint-Germain E, Gaumont-Leclerc MF, Moro A, Ferbeyre G. CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis. Molecular Biology of the Cell. 25: 554-65. PMID 24403608 DOI: 10.1091/Mbc.E13-02-0110 |
0.547 |
|
2014 |
Deschênes-Simard X, Kottakis F, Lessard F, Saint-Germain E, Bourdeau V, Bardeesy N, Ferbeyre G. Abstract 3895: Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins Cancer Research. 74: 3895-3895. DOI: 10.1158/1538-7445.Am2014-3895 |
0.518 |
|
2014 |
Igelmann S, Deschênes-Simard X, Lessard F, Bourdeau V, Ferbeyre G. Abstract 2248: The implication of STAT3 degradation and its mitochondrial functions in cellular senescence Cancer Research. 74: 2248-2248. DOI: 10.1158/1538-7445.Am2014-2248 |
0.457 |
|
2014 |
Lessard F, Bourdeau V, Deschênes-Simard X, Igelmann S, Montero M, Ferbeyre G. Abstract 2246: Senescence as a result of impaired ribosome biogenesis Cancer Research. 74: 2246-2246. DOI: 10.1158/1538-7445.Am2014-2246 |
0.492 |
|
2013 |
Deschênes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette FA, Saba-El-Leil MK, Meloche S, Saad F, Mes-Masson AM, Ferbeyre G. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes & Development. 27: 900-15. PMID 23599344 DOI: 10.1101/Gad.203984.112 |
0.494 |
|
2013 |
Moiseeva O, Deschênes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell. 12: 489-98. PMID 23521863 DOI: 10.1111/Acel.12075 |
0.383 |
|
2012 |
Deschênes-Simard X, Gaumont-Leclerc M, Bourdeau V, Moiseeva O, Forest V, Mallette FA, Lessard F, Saad F, Mes-Masson A, Ferbeyre G. Abstract 4166: Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation Cancer Research. 72: 4166-4166. DOI: 10.1158/1538-7445.Am2012-4166 |
0.47 |
|
2012 |
Aauino MDA, Bourdeau V, Vernier M, Ferbeyre G. Abstract 3952: New advances in regulation of senescence by PML and the PML nuclear bodies Cancer Research. 72: 3952-3952. DOI: 10.1158/1538-7445.Am2012-3952 |
0.49 |
|
2011 |
Moiseeva O, Bourdeau V, Vernier M, Dabauvalle MC, Ferbeyre G. Retinoblastoma-independent regulation of cell proliferation and senescence by the p53-p21 axis in lamin A /C-depleted cells. Aging Cell. 10: 789-97. PMID 21535365 DOI: 10.1111/J.1474-9726.2011.00719.X |
0.457 |
|
2011 |
Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes & Development. 25: 41-50. PMID 21205865 DOI: 10.1101/Gad.1975111 |
0.513 |
|
2011 |
Deschênes-Simard X, Gaumont-Leclerc M, Moiseeva O, Forest V, Bourdeau V, Saad F, Mes-Masson A, Ferbeyre G. Abstract 1061: Context dependent tumor suppressor activity of the ERK pathway explains its inverse correlation with malignancy in prostate neoplasms Cancer Research. 71: 1061-1061. DOI: 10.1158/1538-7445.Am2011-1061 |
0.464 |
|
2010 |
Bourdeau V, Ferbeyre G. Oncogene-Induced Senescence (OIS) as a cellular response to oncogenic stresses Cellular Senescence and Tumor Suppression. 63-83. DOI: 10.1007/978-1-4419-1075-2_3 |
0.372 |
|
2009 |
Palijan A, Fernandes I, Verway M, Kourelis M, Bastien Y, Tavera-Mendoza LE, Sacheli A, Bourdeau V, Mader S, White JH. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression. The Journal of Biological Chemistry. 284: 30275-87. PMID 19744932 DOI: 10.1074/Jbc.M109.051201 |
0.379 |
|
2009 |
Palijan A, Fernandes I, Bastien Y, Tang L, Verway M, Kourelis M, Tavera-Mendoza LE, Li Z, Bourdeau V, Mader S, Yang XJ, White JH. Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. The Journal of Biological Chemistry. 284: 30264-74. PMID 19744931 DOI: 10.1074/Jbc.M109.045526 |
0.389 |
|
2009 |
Moiseeva O, Bourdeau V, Roux A, Deschênes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Molecular and Cellular Biology. 29: 4495-507. PMID 19528227 DOI: 10.1128/Mcb.01868-08 |
0.397 |
|
2009 |
Bourdeau V, Baudry D, Ferbeyre G. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Frontiers in Bioscience (Landmark Edition). 14: 475-85. PMID 19273079 DOI: 10.2741/3256 |
0.379 |
|
2009 |
Vernier M, Bourdeau V, Gaumont-Leclerc M, Beaudry D, Moiseeva O, Forest V, Saad F, Mes-Masson A, Ferbeyre G. Sequestration of Rb/E2F complex into PML-NBs provides a distinct mechanism to control the expression of E2F target genes Cytokine. 48: 89. DOI: 10.1016/J.Cyto.2009.07.323 |
0.302 |
|
2008 |
Bourdeau V, Deschênes J, Laperrière D, Aid M, White JH, Mader S. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Research. 36: 76-93. PMID 17986456 DOI: 10.1093/Nar/Gkm945 |
0.314 |
|
2007 |
Deschênes J, Bourdeau V, White JH, Mader S. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. The Journal of Biological Chemistry. 282: 17335-9. PMID 17463000 DOI: 10.1074/Jbc.C700030200 |
0.363 |
|
2005 |
Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Molecular Endocrinology (Baltimore, Md.). 19: 2685-95. PMID 16002434 DOI: 10.1210/Me.2005-0106 |
0.345 |
|
2004 |
Bourdeau V, Deschênes J, Métivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Molecular Endocrinology (Baltimore, Md.). 18: 1411-27. PMID 15001666 DOI: 10.1210/Me.2003-0441 |
0.32 |
|
1999 |
Bourdeau V, Ferbeyre G, Pageau M, Paquin B, Cedergren R. The distribution of RNA motifs in natural sequences Nucleic Acids Research. 27: 4457-4467. PMID 10536156 DOI: 10.1093/Nar/27.22.4457 |
0.302 |
|
Show low-probability matches. |